UNSPSC 51281651: Gentamicin sulfate

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8X7386QRLV. European Medicines Agency schedules Gentamicin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02327MIG. Gentamicin sulfate generally arises in the molecular formula C21H45N5O11S. The term 'gentamicin sulfate' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule gentamicin sulfate under HS 29419000 and SITC 54139.

Gentamicin sulfate bears US NLM identifiers UMLS ID C0546866 and NCI Concept Code C65803. SMILES: As of Q4 2014, GENTAMICIN SULFATE remains US FDA's Preferred Term for this commodity.

UNSPSC 51281651 Gentamicin sulfate is a Commodity code that maps to pharmaceutical procurement activity, though recent state and local opportunities show significant mismatch between the code's specific drug name and the actual solicitations posted under it. The recent opportunities tagged to this code include procurement of naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and exploratory market intelligence on direct-to-manufacturer prescription programs—none of which center on gentamicin sulfate specifically. State and local buyers under this code span county health departments, city emergency services (fire departments), state health agencies, and multi-state cooperative purchasing alliances; Seminole County, Florida; the City of Tampa; the Texas Health and Human Services Commission; and the Minnesota Department of Administration represent recent active issuers.

The geographic spread of recent activity includes Florida, Texas, and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving multiple states including Oregon. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries (response deadline July 26, 2023), the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a March 13, 2026 deadline, and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products open to manufacturers through authorized wholesalers with proposals due March 26, 2026. The code shows limited genuine activity aligned with gentamicin sulfate procurement; the opportunities posted reflect broader pharmaceutical and medical supply categories that may have been miscoded or batch-tagged across multiple drug and supply categories.